Pharming Group NV (PHAR) — Cash Flow Quality Index
Pharming Group NV (PHAR) has a Cash Flow Quality Index of 1.40x as of December 2025. Operating cash flow of $7.39 Million exceeds net income of $5.29 Million, indicating high earnings quality where cash backs reported profits. Explore PHAR strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pharming Group NV Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Pharming Group NV across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pharming Group NV tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Pharming Group NV (2017–2025)
Year-by-year earnings quality comparison for Pharming Group NV. For live market cap and the full company financial profile, see Pharming Group NV market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 17.51x | $50.07 Million | $2.86 Million | ▲ +1068.6% |
| 2022 | 1.50x | $22.46 Million | $14.99 Million | ▼ -8.6% |
| 2021 | 1.64x | $37.84 Million | $23.08 Million | ▼ -13.5% |
| 2020 | 1.90x | $83.63 Million | $44.09 Million | ▲ +33.8% |
| 2019 | 1.42x | $74.15 Million | $52.30 Million | ▲ +33.4% |
| 2018 | 1.06x | $46.19 Million | $43.46 Million | ▼ -39.1% |
| 2017 | 1.74x | $45.84 Million | $26.29 Million | — |